Table 1.
Baseline characteristics
| Variable | IL-SSG % (n) | Thermotherapy % (n) | P value* |
|---|---|---|---|
| Sex | |||
| M | 77.6% (90) | 74.2% (73) | 0.633 |
| F | 22.4% (25) | 25.8% (25) | – |
| Age | 0.747 | ||
| Young (12–30 years) | 40.5% (47) | 36.1% (36) | |
| Middle age(31–60 years) | 41.4% (48) | 46.4% (45) | |
| Old (> 60 years) | 18.1% (20) | 17.5% (17) | |
| Occupation | 0.155 | ||
| Army | 26.7% (30) | 43.3% (42) | |
| Civilians | 73.3% (85) | 56.7% (56) | |
| Education | 0.274 | ||
| Primary | 26.7% (30) | 18.6% (18) | |
| Secondary | 69.8% (81) | 75.3% (74) | |
| Post-secondary | 3.4% (4) | 6.2% (6) | |
| Durationofillness | 0.832 | ||
| < 3 months | 16.4% (19) | 20·6% (20) | |
| 3–6 months | 37.9% (43) | 37·1% (37) | |
| 7–9 months | 20.7% (24) | 21.6% (21) | |
| 10–12 months | 11.2% (13) | 11.3% (11) | |
| > 12 months | 13.8% (16) | 9.3% (9) | |
| Type of lesion | 0.100 | ||
| Papule | 22.4% (26) | 21.6% (22) | |
| Nodule | 17.2% (20) | 21.6% (21) | |
| Plaque | 6.9% (8) | 0% (0) | |
| Ulcer | 6.9% (8) | 5.2% (5) | |
| Nodular ulcer | 46.6% (53) | 51.5% (50) |
IL-SSG = intralesional sodium stibogluconate.
*
Statistical analysis using χ2 test.